MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹93 Cr | ₹21 Cr | ₹176 Cr | ₹94 Cr | ₹118 Cr |
What is the latest Net Cash Inflow / Outflow ratio of MARKSANS PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹93 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹176 Cr |
| Mar2022 | ₹94 Cr |
| Mar2021 | ₹118 Cr |
How is Net Cash Inflow / Outflow of MARKSANS PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹93 Cr | 343.90 | |
| Mar2024 | ₹21 Cr | -88.16 | |
| Mar2023 | ₹176 Cr | 86.52 | |
| Mar2022 | ₹94 Cr | -20.33 | |
| Mar2021 | ₹118 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹11,194.0 Cr | 3.2% | 21.6% | -1.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,785.0 Cr | 0.4% | -4.6% | 6.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,242.0 Cr | 0.7% | -1.1% | 2.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,058.0 Cr | 2.9% | -1.2% | 42.7% | Stock Analytics | |
| CIPLA | ₹111,180.0 Cr | -1.5% | 5.5% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,149.0 Cr | 0.4% | -0.6% | 1.3% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 3.2% |
21.6% |
-1.7% |
| SENSEX | -0.5% |
-4.3% |
-8.4% |
You may also like the below Video Courses